Pain News and Research

Latest Pain News and Research

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) announced today the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for review to add clinical data regarding the effect of Brintellix (vortioxetine) on certain aspects of cognitive function in adults with Major Depressive Disorder (MDD) to the current product label.

11 Aug 2015

Sigma 1 receptor appears to play vital role in supporting the retina

A receptor that is already a target for treating neurodegenerative disease also appears to play a key role in supporting the retina, scientists report.

11 Aug 2015

Women who conceive babies through IVF at increased risk of experiencing GORD

Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal.

11 Aug 2015

Older patients more likely to be readmitted to hospital after ambulatory surgery

Patients 65 and older who have ambulatory surgery are much more likely to be readmitted to the hospital within 30 days than younger patients, regardless of their health before surgery, reports a new, large national Northwestern Medicine study. The likely cause, based on previous research, is difficulty understanding medication dosing and discharge instructions, as well as cognitive impairment among older patients.

11 Aug 2015

Screening questionnaire helps anesthesia professionals identify SDB symptoms in children prior to surgery

Knowing which risks may come into play before or during surgery is especially important where children are concerned.

11 Aug 2015

Mylan announces launch of Lidocaine Patch 5% in the U.S.

Mylan N.V. today announced the U.S. launch of its Lidocaine Patch 5%, which is the generic version of Endo Pharmaceutical's Lidoderm. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for relief of pain associated with post-herpetic neuralgia.

10 Aug 2015

TNK Therapeutics acquires multiple preclinical and clinical stage CAR-T immunotherapy programs

Sorrento Therapeutics, Inc. announced today that its wholly-owned subsidiary, TNK Therapeutics, Inc., has acquired multiple preclinical and clinical stage chimeric antigen receptor (CAR)-T immunotherapy programs as well as underlying CAR-T technology through the acquisition of two privately-held biotechnology companies.

10 Aug 2015

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Mallinckrodt plc, a leading specialty biopharmaceutical company, and The Gores Group, a global investment firm, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Therakos, Inc. a leading immunotherapy company in a transaction valued at approximately $1.325 billion.

10 Aug 2015

Flowonix Medical's new Patient Therapy Controller approved for market release

Flowonix Medical, Inc., announced today that its newest product, the Patient Therapy Controller (PTC), has been approved for market release. The PTC interfaces with the company's Prometra platform of intrathecal infusion devices. A small, hand-held device with a touch-screen, the PTC allows the patient to initiate a bolus delivery of medication from the implanted pump.

7 Aug 2015

St. Luke’s neurosurgeon partners with Medtronic to perform first live feed neurosurgery

St. Luke’s University Health Network’s functional neurosurgeon Steven Falowski, MD, has partnered with Medtronic medical device company to promote faster and better product development within the field of neuromodulation for patients with pain and disability related to nerve disorders.

7 Aug 2015

Lexicon Pharmaceuticals' revenues decrease to $0.4 million in second quarter 2015

Lexicon Pharmaceuticals, Inc., today reported financial results for the second quarter ended June 30, 2015 and provided an overview of key milestones for the company's lead drug candidates.

7 Aug 2015

New technology that tracks patients' eye movements may accurately measure brain injury

New technology that tracks the eye movements of patients may be a more accurate measure of brain injury than any other diagnostic measurements currently in use, according to a study recently published in the journal Concussion.

7 Aug 2015

Shorter course of whole breast radiation therapy better for women with early stage breast cancer

Women who receive a shorter course of whole breast radiation therapy for early stage disease experience less toxicity and improved quality of life compared to those who undergo a longer course of treatment, researchers report from The University of Texas MD Anderson Cancer Center.

7 Aug 2015

Pennsylvania physicians examine back-to-school health, offer tips for parents and students

As students start heading back to classes for the upcoming academic year, Pennsylvania physicians take a close look at back-to-school health and offer some tips for parents and students who strive to stay in class and not home in bed sick.

7 Aug 2015

Imaging studies required to diagnose traumatic injuries in pregnant women can be safe when used properly

According to a new study in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), imaging studies necessary to diagnose traumatic injuries sustained by pregnant women are safe when used properly.

7 Aug 2015

Report: Florida falling short on policies to prevent, fight cancer

Florida is falling short when it comes to supporting policies and passing legislation to prevent and reduce suffering and death from cancer. According to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, Florida did not measure up to policy recommendations in any of the nine issue areas ranked.

6 Aug 2015

Meniscal transplant surgery reduces pain, improves knee function in most patients younger than age 50

Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.

6 Aug 2015

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

Allergan, plc. today announced that the company has received approval from the U.S. Food and Drug Administration to market 28 additional styles of Natrelle 410 silicone-filled breast implants, giving surgeons and patients more options to achieve desired outcomes.

6 Aug 2015

In vitro testing provides proof of concept for osteopathic manipulative therapy

In vitro studies of the cellular effects of modeled osteopathic manipulative therapy (OMT) provide proof of concept for the manual techniques practiced by doctors of osteopathic medicine (DOs), according to researchers from the University of Arizona College of Medicine - Phoenix.

5 Aug 2015

Non-surgical approach to treating 'double chins'

UT Southwestern Medical Center plastic surgeons have a non-surgical approach to treating "double chins" − the moderate-to-severe fat below the chin using an FDA-approved drug that when injected into tissue destroys fat cells.

5 Aug 2015

Pain News and Research

Latest Pain News and Research

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Sigma 1 receptor appears to play vital role in supporting the retina

Women who conceive babies through IVF at increased risk of experiencing GORD

Older patients more likely to be readmitted to hospital after ambulatory surgery

Screening questionnaire helps anesthesia professionals identify SDB symptoms in children prior to surgery

Mylan announces launch of Lidocaine Patch 5% in the U.S.

TNK Therapeutics acquires multiple preclinical and clinical stage CAR-T immunotherapy programs

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Flowonix Medical's new Patient Therapy Controller approved for market release

St. Luke’s neurosurgeon partners with Medtronic to perform first live feed neurosurgery

Lexicon Pharmaceuticals' revenues decrease to $0.4 million in second quarter 2015

New technology that tracks patients' eye movements may accurately measure brain injury

Shorter course of whole breast radiation therapy better for women with early stage breast cancer

Pennsylvania physicians examine back-to-school health, offer tips for parents and students

Imaging studies required to diagnose traumatic injuries in pregnant women can be safe when used properly

Report: Florida falling short on policies to prevent, fight cancer

Meniscal transplant surgery reduces pain, improves knee function in most patients younger than age 50

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

In vitro testing provides proof of concept for osteopathic manipulative therapy

Non-surgical approach to treating 'double chins'

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in